Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2014-09-10 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-NAZAIRE (44600), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE AUFAUVRE PAVAGEAU is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-NAZAIRE (44600),
this company of category PME
shows in 2021 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE AUFAUVRE PAVAGEAU (SIREN 804494045)
Indicator
2024
2023
2021
2020
2019
2018
2016
Revenue
N/C
N/C
2 099 703 €
N/C
N/C
N/C
N/C
Net income
140 294 €
169 517 €
128 609 €
117 349 €
129 510 €
142 914 €
149 350 €
EBITDA
N/C
N/C
192 322 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.1%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE AUFAUVRE PAVAGEAU generates positive net income of 140 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 149 k€ -> 140 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
140 294 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 71%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
71.369%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.758%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2023
2024
Debt ratio
313.209
160.468
121.939
170.968
137.774
85.72
71.369
Financial autonomy
20.885
35.027
40.701
33.107
37.434
47.592
51.758
Repayment capacity
None
None
None
None
7.693
None
None
Cash flow / Revenue
None%
None%
None%
None%
7.088%
None%
None%
Sector positioning
Debt ratio
71.372024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-7 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE AUFAUVRE... (71.37) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
51.76%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+12 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE AUFAUVRE... (51.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
7.69 years2021
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Average
In 2021, the repayment capacity of SELARL PHARMACIE AUFAUVRE... (7.69) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 250.43. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2021
2023
2024
Liquidity ratio
174.912
253.754
245.141
238.526
234.56
248.923
250.432
Interest coverage
None
None
None
None
5.643
None
None
Sector positioning
Liquidity ratio
250.432024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+6 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE AUFAUVRE... (250.43) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
5.64x2021
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Good
In 2021, the interest coverage of SELARL PHARMACIE AUFAUVRE... (5.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE AUFAUVRE PAVAGEAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
215 220 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
34
0
0
Customer payment term (days)
98
131
163
117
8
0
0
Supplier payment term (days)
793
665
753
740
43
0
0
Positioning of SELARL PHARMACIE AUFAUVRE PAVAGEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE AUFAUVRE PAVAGEAU is estimated at
1 958 607 €
(range 1 363 943€ - 2 930 189€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1363k€1958k€2930k€
1 958 607 €Range: 1 363 943€ - 2 930 189€
NAF 5 année 2024
Valuation method used
Net Income Multiple
140 294 €
×
14.0x
=1 958 608 €
Range: 1 363 944€ - 2 930 190€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE AUFAUVRE PAVAGEAU with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE AUFAUVRE PAVAGEAU
What is the revenue of SELARL PHARMACIE AUFAUVRE PAVAGEAU ?
The revenue of SELARL PHARMACIE AUFAUVRE PAVAGEAU in 2021 is 2.1 M€.
Is SELARL PHARMACIE AUFAUVRE PAVAGEAU profitable?
Yes, SELARL PHARMACIE AUFAUVRE PAVAGEAU generated a net profit of 140 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE AUFAUVRE PAVAGEAU ?
The headquarters of SELARL PHARMACIE AUFAUVRE PAVAGEAU is located in SAINT-NAZAIRE (44600), in the department Loire-Atlantique.
Where to find the tax return of SELARL PHARMACIE AUFAUVRE PAVAGEAU ?
The tax return of SELARL PHARMACIE AUFAUVRE PAVAGEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE AUFAUVRE PAVAGEAU operate?
SELARL PHARMACIE AUFAUVRE PAVAGEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart